Literature DB >> 3076189

Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.

A Vecchiarelli1, R Mazzolla, S Farinelli, A Cassone, F Bistoni.   

Abstract

Intravenous inoculation of an attenuated agerminative strain of Candida albicans (PCA-2) of low virulence, but not of two other species of Candida of low virulence (C. parapsilosis and C. viswanathii) into CD2F1 mice conferred protection against the highly virulent microbes C. albicans CA-6, Staphylococcus aureus and Aspergillus fumigatus. To provide protection, a definite inoculum size (10(6) cells per mouse) resulting in organ colonization and establishment of a long-lasting chronic infection with PCA-2 was needed. An inoculum of 10(5) cells gave rise to transient kidney colonization whereas inocula greater than 10(6) cells led to acute septicaemia and eventual death. Chronic infection of mice following inoculation of 10(6) PCA-2 cells was accompanied by detectable mannoprotein antigen levels in the serum (30-70 ng ml-1) while specific antibodies did not appear until 14 d after inoculation, at which time low antimannan antibody was present (ELISA titre 1:40-1:80). Chronic infection was characterized by the presence in the kidneys of 2-3 x 10(6) c.f.u. of PCA-2 for at least 40 d after inoculation. Pharmacological modulation of the host through administration of either an anti-Candida drug, amphotericin B, or an immunosuppressive agent, cyclophosphamide, strongly supported the premise that the anti-infectious state conferred by PCA-2 'immunization' correlated with the maintenance of a sufficient number of PCA-2 in vivo. Protection was 'switched on' when 2-3 x 10(5) cells were present in the kidneys. It was maximal at a kidney count of 2-3 x 10(6) c.f.u. of PCA-2, and promptly declined when the number of PCA-2 cells in the kidney fell below 2 x 10(5). Mice chronically infected with PCA-2 had splenic macrophages with pronounced candidacidal activity in vitro. Modulation of the growth of PCA-2 in vivo, which determined activation or deactivation of the protective state, was paralleled by a similar modulation in macrophage activation, showing that in all cases resistance to virulent organisms persisted as long as macrophage activation was present. The results demonstrate that a critical in vivo antigenic load is crucial for the occurrence of resistance to infection and suggests that macrophages could be involved in this protection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3076189     DOI: 10.1099/00221287-134-9-2583

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  15 in total

1.  Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.

Authors:  E Cenci; L Romani; A Vecchiarelli; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

2.  An overview of current Italian studies on bacterial pathogenesis.

Authors:  G Falcone
Journal:  World J Microbiol Biotechnol       Date:  1992-12       Impact factor: 3.312

3.  Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

Authors:  L Romani; S Mocci; C Bietta; L Lanfaloni; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  Group B streptococci persist inside macrophages.

Authors:  P Cornacchione; L Scaringi; K Fettucciari; E Rosati; R Sabatini; G Orefici; C von Hunolstein; A Modesti; A Modica; F Minelli; P Marconi
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

5.  Early differential molecular response of a macrophage cell line to yeast and hyphal forms of Candida albicans.

Authors:  E Blasi; L Pitzurra; M Puliti; L Lanfrancone; F Bistoni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.

Authors:  E Blasi; R Barluzzi; R Mazzolla; F Bistoni
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Differential susceptibility of yeast and hyphal forms of Candida albicans to proteolytic activity of macrophages.

Authors:  E Blasi; L Pitzurra; A R Chimienti; R Mazzolla; M Puliti; R Barluzzi; F Bistoni
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

Review 8.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

9.  Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration.

Authors:  E Cenci; A Bartocci; P Puccetti; S Mocci; E R Stanley; F Bistoni
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.